Patents – Page 5
-
Business
India revokes more pharma patents
Original molecule patent stands, but a new salt form is ‘not innovative’
-
BusinessLilly freezes pay as patent cliff looms
Drugmaker targets $400 million savings as two key patents near expiry
-
Business
Ups and downs for erectile dysfunction drugs
First new drug in a decade approved in Europe as Viagra patent expires
-
NewsUS supreme court rules genes can't be patented
Breast cancer test company at centre of case can still rely on patents on non-naturally occurring DNA
-
Business
Pfizer and Takeda win $2.15bn in patent payout
Teva and Sun fined for selling generics before patent expiry
-
Business
Japanese pharma opens compound vaults
Molecule libraries to be screened for neglected diseases
-
Business
Objections raised to GSK pay-for-delay deals
The UK Office of Fair Trading believes deals to delay generic drugs infringed competition laws
-
Business
DuPont and Monsanto settle Roundup dispute
Firms drop expensive ongoing litigation in favour of a licensing deal
-
BusinessIndia rejects Novartis patent appeal
Supreme court uphold decision to refuse protection for Glivec
-
Business
Russian investment vehicle sets sights on innovative drugs
Rusnano hopes to make a killing by investing in new technologies in the pharmaceutical sector
-
BusinessUK considers patent rule change for trials
Government to change law that organisations say makes the country less appealing as a location for clinical trials
-
BusinessIndia pushes for emergency drug licences
Government looks set to force licensing of three patented cancer drugs
-
Business2012 pharma industry roundup
What were the bigger stories? And how did the industry fare overall?
-
Business
Single EU patent agreed for 2014
European commission says long awaited single patent will cut cost of filing by 87%
-
BusinessChemists contribute to prior art hunt
A crowdsourcing website that pays for prior art is gaining popularity – can chemists make money?
-
Business
Kevlar equivalent banned for 20 years
US rules in favour of DuPont in Kevlar trade secrets case
-
BusinessCrowdsourcing science site to launch
Marblar aims to find uses for neglected patents by ‘gamifying’ the technology transfer process
-
BusinessIrish pharma exports tumble
Seven of the top 10 drugs going off patent between 2011 and 2014 are produced in Ireland
-
Business
Monsanto wins $1bn in patent case
Monsanto had claimed that DuPont infringed its patents covering glyphosate pesticide products